Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells
- 30 November 2001
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 87 (5) , 424-429
- https://doi.org/10.1016/s1081-1206(10)62926-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Olopatadine inhibits TNFα release from human conjunctival mast cellsAnnals of Allergy, Asthma & Immunology, 2000
- Molecular consequences of human mast cell activation following immunoglobulin E–high-affinity immunoglobulin E receptor (IgE–FcϵRI) interactionBiochemical Pharmacology, 1999
- Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitisAnnals of Allergy, Asthma & Immunology, 1999
- Mast cells in psoriatic skin are strongly positive for interferon-gammaBritish Journal of Dermatology, 1999
- Cord blood‐derived human cultured mast cells produce transforming growth factor β1Clinical and Experimental Allergy, 1999
- Comparative Effects of Topical Ocular Anti-Allergy Drugs on Human Conjunctival Mast CellsAnnals of Allergy, Asthma & Immunology, 1997
- In situ hybridization analysis of ICAM-1 (CD54) mRNA on conjunctival epithelium during allergic inflammationClinical and Experimental Allergy, 1997
- Heterogeneity of ICAM‐1 expression, and cytokine regulation of ICAM‐1 expression, in skin and oral keratinocytesJournal of Oral Pathology & Medicine, 1996
- Interleukin 4 is localized to and released by human mast cells.The Journal of Experimental Medicine, 1992
- Atopic conjunctivitisActa Ophthalmologica, 1988